212 related articles for article (PubMed ID: 1701508)
1. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast.
Howeedy AA; Virtanen I; Laitinen L; Gould NS; Koukoulis GK; Gould VE
Lab Invest; 1990 Dec; 63(6):798-806. PubMed ID: 1701508
[TBL] [Abstract][Full Text] [Related]
2. Distribution of tenascin, cellular fibronectins and integrins in the normal, hyperplastic and neoplastic breast.
Koukoulis GK; Howeedy AA; Korhonen M; Virtanen I; Gould VE
J Submicrosc Cytol Pathol; 1993 Apr; 25(2):285-95. PubMed ID: 7686813
[TBL] [Abstract][Full Text] [Related]
3. Extracellular matrix proteins and their receptors in the normal, hyperplastic and neoplastic breast.
Gould VE; Koukoulis GK; Virtanen I
Cell Differ Dev; 1990 Dec; 32(3):409-16. PubMed ID: 1711920
[TBL] [Abstract][Full Text] [Related]
4. Coexpression patterns of vimentin and glial filament protein with cytokeratins in the normal, hyperplastic, and neoplastic breast.
Gould VE; Koukoulis GK; Jansson DS; Nagle RB; Franke WW; Moll R
Am J Pathol; 1990 Nov; 137(5):1143-55. PubMed ID: 1700618
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of the expression of tenascin and established prognostic factors in human breast cancer.
Moch H; Torhorst J; Dürmüller U; Feichter GE; Sauter G; Gudat F
Pathol Res Pract; 1993 Jun; 189(5):510-4. PubMed ID: 7690952
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of integrins in the normal, hyperplastic, and neoplastic breast. Correlations with their functions as receptors and cell adhesion molecules.
Koukoulis GK; Virtanen I; Korhonen M; Laitinen L; Quaranta V; Gould VE
Am J Pathol; 1991 Oct; 139(4):787-99. PubMed ID: 1928301
[TBL] [Abstract][Full Text] [Related]
7. Tenascin expression in normal and abnormal human endometrium.
Sasano H; Nagura H; Watanabe K; Ito K; Tsuiki A; Sato S; Yajima A; Kusakabe M; Sakakura T
Mod Pathol; 1993 May; 6(3):323-6. PubMed ID: 7688462
[TBL] [Abstract][Full Text] [Related]
8. Alteration of stromal protein and integrin expression in breast--a marker of premalignant change?
Jones JL; Critchley DR; Walker RA
J Pathol; 1992 Aug; 167(4):399-406. PubMed ID: 1383484
[TBL] [Abstract][Full Text] [Related]
9. Epithelial cells are an important source of tenascin in normal and malignant human breast tissue.
Lightner VA; Marks JR; McCachren SS
Exp Cell Res; 1994 Feb; 210(2):177-84. PubMed ID: 7507849
[TBL] [Abstract][Full Text] [Related]
10. Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma.
Tuszynski GP; Nicosia RF
Lab Invest; 1994 Feb; 70(2):228-33. PubMed ID: 7511188
[TBL] [Abstract][Full Text] [Related]
11. Enhanced tenascin expression in cervical and vulvar koilocytotic lesions.
Tiitta O; Wahlström T; Paavonen J; Linnala A; Sharma S; Gould VE; Virtanen I
Am J Pathol; 1992 Oct; 141(4):907-13. PubMed ID: 1384340
[TBL] [Abstract][Full Text] [Related]
12. Tenascin-A marker for the malignant potential of preinvasive breast cancers.
Goepel C; Buchmann J; Schultka R; Koelbl H
Gynecol Oncol; 2000 Dec; 79(3):372-8. PubMed ID: 11104607
[TBL] [Abstract][Full Text] [Related]
13. Tenascin expression in astrocytomas correlates with angiogenesis.
Zagzag D; Friedlander DR; Miller DC; Dosik J; Cangiarella J; Kostianovsky M; Cohen H; Grumet M; Greco MA
Cancer Res; 1995 Feb; 55(4):907-14. PubMed ID: 7531617
[TBL] [Abstract][Full Text] [Related]
14. Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast.
Clezardin P; Frappart L; Clerget M; Pechoux C; Delmas PD
Cancer Res; 1993 Mar; 53(6):1421-30. PubMed ID: 7680285
[TBL] [Abstract][Full Text] [Related]
15. The phosphorylated form of connexin43 is up-regulated in breast hyperplasias and carcinomas and in their neoformed capillaries.
Gould VE; Mosquera JM; Leykauf K; Gattuso P; Dürst M; Alonso A
Hum Pathol; 2005 May; 36(5):536-45. PubMed ID: 15948121
[TBL] [Abstract][Full Text] [Related]
16. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.
Moll R; Mitze M; Frixen UH; Birchmeier W
Am J Pathol; 1993 Dec; 143(6):1731-42. PubMed ID: 8256859
[TBL] [Abstract][Full Text] [Related]
17. [Relationship of an extracellular matrix protein, tenascin and breast diseases].
Ishihara A; Yatani R; Sakakura T
Rinsho Byori; 1993 Oct; 41(10):1099-107. PubMed ID: 7504753
[TBL] [Abstract][Full Text] [Related]
18. Mammary cancer antigen recognized by monoclonal antibody B72.3 in apocrine metaplasia of the human breast.
Castagna M; Nuti M; Squartini F
Cancer Res; 1987 Feb; 47(3):902-6. PubMed ID: 3542197
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical staining patterns of tenascin in invasive breast carcinomas.
Shoji T; Kamiya T; Tsubura A; Hatano T; Sakakura T; Yamamoto M; Morii S
Virchows Arch A Pathol Anat Histopathol; 1992; 421(1):53-6. PubMed ID: 1378984
[TBL] [Abstract][Full Text] [Related]
20. Tenascin induction in tenascin nonproducing carcinoma cell lines in vivo and by TGF-beta 1 in vitro.
Sakai T; Kawakatsu H; Ohta M; Saito M
J Cell Physiol; 1994 Jun; 159(3):561-72. PubMed ID: 7514613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
